What makes for a good IHI project? A word from our director
What makes for a good IHI project? That was one of the most frequent questions I had during our recent brokerage event – our annual forum to foster bold, interdisciplinary collaborations ahead of the 2026 calls. My answer was “ambition to transform” – our projects are scientifically ambitious, drawing on interdisciplinary consortia to push beyond the state of the art, aiming for a transformative impact on the field.
We see the outcomes of these ambitions in our bibliometrics study, which shows how our projects continue to publish excellent science, recognised and cited by peers globally. What’s more, it is the collaborative, cross-sectorial, and international papers that are making the biggest impact on the field – a testament to the IHI strategy of fostering bold collaborations. Scientific excellence is important to IHI; the programme should give young European talent an opportunity to build strong scientific careers at the same time as we strengthen collaboration between academia, industry and civil society.
However, a good IHI project also has the ambition to build lasting impacts on health, care and society. This needs the involvement of healthcare, regulators and the people living with disease. We had a lot of insightful advice on how to effectively include these groups in consortia at the brokerage event – and in the run-up to Christmas we also have exciting webinars on these topics. If you are working on a proposal for IHI call 12, don’t miss the newly published call texts, the discussion on regulatory impact, or the lively fireside chat on patient advocacy!
Niklas Blomberg, IHI Executive Director
We see the outcomes of these ambitions in our bibliometrics study, which shows how our projects continue to publish excellent science, recognised and cited by peers globally. What’s more, it is the collaborative, cross-sectorial, and international papers that are making the biggest impact on the field – a testament to the IHI strategy of fostering bold collaborations. Scientific excellence is important to IHI; the programme should give young European talent an opportunity to build strong scientific careers at the same time as we strengthen collaboration between academia, industry and civil society.
However, a good IHI project also has the ambition to build lasting impacts on health, care and society. This needs the involvement of healthcare, regulators and the people living with disease. We had a lot of insightful advice on how to effectively include these groups in consortia at the brokerage event – and in the run-up to Christmas we also have exciting webinars on these topics. If you are working on a proposal for IHI call 12, don’t miss the newly published call texts, the discussion on regulatory impact, or the lively fireside chat on patient advocacy!
Niklas Blomberg, IHI Executive Director
IHI Call Days for call 12 – registration open!
The IHI Call Days for call 12 will feature online info sessions on the content (topics), rules and procedures, and financial aspects of the call.
Dates: 19-20 January 2026.
Register here
Dates: 19-20 January 2026.
Read the updated draft text of IHI call 12
Get ahead of the game and use the draft call text to start preparing your proposal and building your consortium.
Catch up on the IHI Brokerage Event 2025
In addition to pitches for project proposals, the Brokerage Event featured presentations and panel discussions packed with tips for potential applicants. All presentations and recordings are available online.
Get informed – study the key call documents
Key call documents like our guide for applicants, FAQ, and guide for contributing partners contain all the information you need to prepare a strong proposal.
IHI Brokerage Platform still open for registration and networking
The Brokerage Platform will remain open for new registrations and networking until the call deadline. It’s a great place to showcase your expertise, find partners, and share project proposal ideas.
IMI ranks first compared to other funding bodies for high citation impact
A report carried out by Nature Research Intelligence indicates that one-third of IMI research papers are within the top 10% of most cited papers in their field.
Read more
IHI heart disease project devises AI-based tool to standardise health data
iCARE4CVD has delivered an innovative new tool to harmonise data in the cardiovascular disease field, a key step on the project’s path towards advancing more personalised care.
Trusted sources of information on medicine use for pregnant and breastfeeding women
IMI project ConcePTION’s Meds4Mums2B app and knowledge bank provide reliable information on medicine safety during pregnancy & breastfeeding.
How to cure type 1 diabetes: transforming research into policy change
The EDENT1FI and INNODIA projects contributed to recommendations for policymakers published by the European Diabetes Forum which outlines how Europe can make type 1 diabetes a disease of the past.
CarePath to pioneer personalised support for treatment management
The new project will generate resources to help people with chronic conditions to manage their treatment in ways that fit their lifestyles and needs.
Webinar: Discover how partnerships are joining forces to combat TB
Join us on 9 December and find out how projects funded by IMI and EDCTP are advancing the development of a new way of treating tuberculosis (TB).
Webinar: What is regulatory impact and how can you achieve it?
Registration is open for a webinar on 10 December that will set out the best ways for IHI projects to engage with regulators and achieve regulatory impact.
Watch our fireside chat with patient advocate Peter Kapitein
Watch the recording of our fireside chat with Peter Kapitein, patient advocate, CEO of Inspire2Live, and member of the IHI Science and Innovation Panel.
How public-private partnerships can help to tackle neurodegenerative diseases
Read the report of our workshop examining project outcomes, challenges and opportunities regarding neurodegenerative diseases in Europe.